Literature DB >> 21734573

Serum amyloid A in atherosclerosis.

Victoria L King1, Joel Thompson, Lisa R Tannock.   

Abstract

PURPOSE OF REVIEW: Serum amyloid A (SAA) is a family of acute-phase proteins which are shown to correlate with cardiovascular disease, but whether this SAA contributes causally to atherosclerosis development or reflects underlying disease or risk factors remains unclear. RECENT
FINDINGS: SAA has been detected within atherosclerotic lesions and within adipose tissue where it is hypothesized that it may play a contributory role in disease development. In the acute-phase response SAA is synthesized by the liver and transported primarily in association with HDL. However, there is a growing literature suggesting that localized synthesis of SAA within the vasculature, or adipose tissue, may play a distinct role in disease development. Furthermore, SAA can be found in association with apoB-containing lipoproteins, in which its biological activity may be different.
SUMMARY: This review will discuss recent experimental evidence supporting a causal role of SAA with atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21734573     DOI: 10.1097/MOL.0b013e3283488c39

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  41 in total

1.  Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation.

Authors:  Andrzej Witkowski; Gary K L Chan; Jennifer C Boatz; Nancy J Li; Ayuka P Inoue; Jaclyn C Wong; Patrick C A van der Wel; Giorgio Cavigiolio
Journal:  FASEB J       Date:  2018-01-17       Impact factor: 5.191

2.  Association of rheumatoid arthritis disease activity and antibodies to periodontal bacteria with serum lipoprotein profile in drug naive patients.

Authors:  Aulikki Kononoff; Pia Elfving; Pirkko Pussinen; Sohvi Hörkkö; Hannu Kautiainen; Leena Arstila; Leena Laasonen; Elina Savolainen; Helena Niinisalo; Jarno Rutanen; Olga Marjoniemi; Mari Hämäläinen; Katriina Vuolteenaho; Eeva Moilanen; Oili Kaipiainen-Seppänen
Journal:  Ann Med       Date:  2020-02-10       Impact factor: 4.709

3.  Serum amyloid A induces interleukin-1β secretion from keratinocytes via the NACHT, LRR and PYD domains-containing protein 3 inflammasome.

Authors:  N Yu; S Liu; X Yi; S Zhang; Y Ding
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

4.  Serum amyloid A and pairing formyl peptide receptor 2 are expressed in corneas and involved in inflammation-mediated neovascularization.

Authors:  Sheng-Wei Ren; Xia Qi; Chang-Kai Jia; Yi-Qiang Wang
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

5.  Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages.

Authors:  Balázs Koscsó; Balázs Csóka; Endre Kókai; Zoltán H Németh; Pál Pacher; László Virág; S Joseph Leibovich; György Haskó
Journal:  J Leukoc Biol       Date:  2013-08-06       Impact factor: 4.962

6.  Serum amyloid A induces interleukin-33 expression through an IRF7-dependent pathway.

Authors:  Lei Sun; Ziyan Zhu; Ni Cheng; Qian Yan; Richard D Ye
Journal:  Eur J Immunol       Date:  2014-05-22       Impact factor: 5.532

Review 7.  The impact of bariatric surgery on inflammation: quenching the fire of obesity?

Authors:  Samar Hafida; Tooraj Mirshahi; Barbara S Nikolajczyk
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-10       Impact factor: 3.243

8.  Glomerular cell death and inflammation with high-protein diet and diabetes.

Authors:  Rick L Meek; Renee C LeBoeuf; Sandeep A Saha; Charles E Alpers; Kelly L Hudkins; Sheryl K Cooney; Robert J Anderberg; Katherine R Tuttle
Journal:  Nephrol Dial Transplant       Date:  2013-01-12       Impact factor: 5.992

Review 9.  Serum amyloid A1: Structure, function and gene polymorphism.

Authors:  Lei Sun; Richard D Ye
Journal:  Gene       Date:  2016-03-03       Impact factor: 3.688

10.  Serum amyloid A impairs the antiinflammatory properties of HDL.

Authors:  Chang Yeop Han; Chongren Tang; Myriam E Guevara; Hao Wei; Tomasz Wietecha; Baohai Shao; Savitha Subramanian; Mohamed Omer; Shari Wang; Kevin D O'Brien; Santica M Marcovina; Thomas N Wight; Tomas Vaisar; Maria C de Beer; Frederick C de Beer; William R Osborne; Keith B Elkon; Alan Chait
Journal:  J Clin Invest       Date:  2015-12-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.